Institutional Review Board (IRB) Guidance for Harm Reduction Programs
| dc.contributor.author | Bayla Ostrach | |
| dc.contributor.author | Lesly-Marie Buer | |
| dc.contributor.author | Brittany Price | |
| dc.contributor.author | Elise Healy | |
| dc.contributor.author | Katelyn Benhoff | |
| dc.contributor.author | Kelly Knudtson | |
| dc.contributor.author | Sara Glick | |
| dc.date.accessioned | 2024-11-11T15:37:53Z | |
| dc.date.available | 2024-11-11T15:37:53Z | |
| dc.date.issued | 2024-09-19 | |
| dc.description.abstract | This document is to help harm reduction programs understand what an Institutional Review Board (IRB) is, what IRBs do, and when to submit a data collection plan to an IRB. We provide an overview of IRBs, explain what it means to collect data from human subjects, discuss the benefits of using an IRB, offer ways to access an IRB, and tell you what to expect when submitting for IRB review. | |
| dc.description.sponsorship | Opioid Response Network. Funding for this initiative was made possible (in part) by grant no. 1H79TI085588 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. | |
| dc.identifier.uri | https://hdl.handle.net/1773/52648 | |
| dc.language.iso | en_US | |
| dc.rights | Attribution-NonCommercial 3.0 United States | en |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc/3.0/us/ | |
| dc.subject | Harm reduction | |
| dc.subject | Syringe services | |
| dc.subject | Institutional Review Board | |
| dc.subject | Research ethics | |
| dc.title | Institutional Review Board (IRB) Guidance for Harm Reduction Programs | |
| dc.type | Technical Report |